Phase II clinical trial - Appareil pulmonaire

CheckMate 592 (CA209-592)
Appareil pulmonaire
Ouvert depuis le: 03.21.2019
Site: Paris
Public cible
Adulte
Protocol Title: An Exploratory Study of the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Treatment-Naive Stage IV or recurrent Non-Small Cell Lung Cancer (NSCLC).
Description de l'essai

The purpose of this study is to explore the possible links between participant characteristics and their cancer, with how effective the combination of nivolumab with ipilimumab is, in participants with Stage IV or recurrent Non-Small Cell Lung Cancer (NSCLC).